EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010)
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to test the experimental reproducibility and within-subject
variability of qEEG (quantitative electroencephalogram) using two probe compounds: MK3134 and
lorazepam.
This study will test the hypothesis that EEG (Electroencephalogram) theta power, averaged
across a topographical region of interest is decreased 6 hours after administration of MK3134
compared to placebo.
The objective of this study is to test the experimental reproducibility and within-subject
variability of qEEG using two probe compounds: MK3134 and lorazepam.